NISHIYAMA Hiroyuki
- Articles
- IMvigor011: A global, double-blind, randomised phase III study of atezolizumab (atezo; anti-PD-L1) vs placebo (pbo) as adjuvant therapy in patients (pts) with high-risk muscle-invasive bladder cancer (MIBC) who are circulating tumour (ct)DNA plus post cystectomy
Powles T. B.; Gschwend J. E.; Bracarda S.; Castellano D....
ANNALS OF ONCOLOGY/32(5)/pp.S721-S721, 2021 - KEYNOTE-676 cohort B: Randomized comparator-controlled cohort to evaluate efficacy and safety of pembrolizumab (pembro) plus bacillus Calmette-Guerin (BCG) in patients with high-risk BCG treatment-naive non-muscle invasive bladder cancer (HR NMIBC)
Shariat S. F.; Steinberg G.; Kamat A. M.; Shore N. D.; Al...
ANNALS OF ONCOLOGY/32(5)/pp.S723-S723, 2021 - Current status and future perspectives of immunotherapy against urothelial and kidney cancer
Kobayashi Takashi; Takeuchi Ario; Nishiyama Hiroyuki; ...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY/51(10)/pp.1481-1492, 2021-10 - Impact of the objective response to and number of cycles of platinum-based first-line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab
Kato Minoru; Kobayashi Takashi; Matsui Yoshiyuki; Ito ...
INTERNATIONAL JOURNAL OF UROLOGY/Epub, 2021-09 - Prevalence of Germline Variants in a Large Cohort of Japanese Patients with Pheochromocytoma and/or Paraganglioma
Yonamine Masato; Wasano Koichiro; Aita Yuichi; Sugasaw...
CANCERS/13(16), 2021-08 - Impact of Early Exposure to Simulation Program on Undergraduate Medical Students' Interest in Urology
Kimura Tomokazu; Kojo Kosuke; Shiga Masanobu; Chihara Ic...
JOURNAL OF MEDICAL EDUCATION AND CURRICULAR DEVELOPMENT/8, 2021-05 - Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer outcomes in patients without radical cystectomy
Iida Kota; Miyake Makito; Murakami Kaoru; Komiyama Mo...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/26(11)/pp.2104-2112, 2021-11 - Outcomes of axitinib versus sunitinib as first-line therapy to patients with metastatic renal cell carcinoma in the immune-oncology era
Numakura Kazuyuki; Muto Yumin; Naito Sei; Hatakeyama Shi...
CANCER MEDICINE/10(17)/pp.5839-5846, 2021-09 - Is real-time detection based on probability map of bladder tumor possible in clinic cystoscopy using deep learning?
Ikeda A.; Kochi Y.; Nosato H.; Negoro H.; Sakanashi H.; M...
EUROPEAN UROLOGY/79(1)/pp.S1756-S1756, 2021-06 - Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancer
Shiota Masaki; Terada Naoki; Kitamura Hiroshi; Kojima Ta...
CANCER SCIENCE/112(9)/pp.3616-3626, 2021-09 - Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis
Kobayashi Mizuki; Narita Shintaro; Matsui Yoshiyuki; K...
BJU INTERNATIONAL/Epub, 2021-06 - Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
Balar Arjun V; Kamat Ashish M.; Kulkarni Girish S.; Uc...
LANCET ONCOLOGY/22(7)/pp.919-930, 2021-07 - Pre-pembrolizumab neutrophil-to-lymphocyte ratio (NLR) predicts the efficacy of second-line pembrolizumab treatment in urothelial cancer regardless of the pre-chemo NLR
Kobayashi Takashi; Ito Katsuhiro; Kojima Takahiro; Mar...
CANCER IMMUNOLOGY IMMUNOTHERAPY/Epub, 2021-07 - Prognosis of Japanese metastatic renal cell carcinoma patients in the targeted therapy era
Naito Sei; Kato Tomoyuki; Numakura Kazuyuki; Hatakeyam...
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY/26(10)/pp.1947-1954, 2021-10 - Intravesical Bacillus Calmette-Guerin Treatment for T1 High-Grade Non-Muscle Invasive Bladder Cancer with Divergent Differentiation or Variant Morphologies
Miyake Makito; Nishimura Nobutaka; Iida Kota; Fujii T...
CANCERS/13(11), 2021-06 - Advanced germ cell tumor patients undergoing post-chemotherapy retroperitoneal lymph node dissection: Impact of residual teratoma on prognosis
Nitta Satoshi; Kawai Koji; Kimura Tomokazu; Kandori S...
INTERNATIONAL JOURNAL OF UROLOGY/28(8)/pp.840-847, 2021-08 - ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
Powles Thomas; Assaf Zoe June; Davarpanah Nicole; Banc...
NATURE/595/pp.432-437, 2021-06 - Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort
Ito Katsuhiro; Kobayashi Takashi; Kojima Takahiro; Hik...
CANCER MEDICINE/10(10)/pp.3188-3196, 2021-05 - Discrepancy between clinical and pathological T stages in upper urinary tract urothelial carcinoma: Analysis of the Hospital-Based Cancer Registry data in Japan
Shiga Masanobu; Nagumo Yoshiyuki; Chihara Ichiro; Nitt...
INTERNATIONAL JOURNAL OF UROLOGY/28(8)/pp.814-819, 2021-08 - Perioperative pembrolizumab therapy in muscle-invasive bladder cancer: Phase III KEYNOTE-866 and KEYNOTE-905/EV-303
Galsky Matthew D.; Hoimes Christopher J.; Necchi Andre...
FUTURE ONCOLOGY/17(24)/pp.3137-3150, 2021-05 - A phase III, randomized, open-label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine plus cisplatin for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (NIAGARA).
Powles Thomas; Meeks Joshua J.; Galsky Matt D.; Van de...
JOURNAL OF CLINICAL ONCOLOGY/39(6::S), 2021-02 - The comparison of cytoreductive nephrectomy (CN) with tyrosine kinase inhibitor therapy alone in patients with primary metastatic renal cell carcinoma (mRCC).
Hatakeyama Shingo; Naito Sei; Numakura Kazuyuki; Kato Re...
JOURNAL OF CLINICAL ONCOLOGY/39(6::S), 2021-02 - Pembrolizumab for the treatment of patients with high-risk (HR) non-muscle-invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin: Extended follow-up of KEYNOTE-057 cohort A.
Balar Arjun Vasant; Kamat Ashish M.; Kulkarni Girish S...
JOURNAL OF CLINICAL ONCOLOGY/39(6::S), 2021-02 - Cystoscopic Imaging for Bladder Cancer Detection Based on Stepwise Organic Transfer Learning with a Pretrained Convolutional Neural Network.
Ikeda A; Nosato H; Kochi Y; Negoro H; Kojima T; Sakanashi...
J Endourol., 2021-03 - 後腹膜鏡下手術にて摘除した横隔膜原発気管支原生嚢胞の1例
田中 隆造; 星 昭夫; 山口 茜; 野中 遥奈; 新田 聡; 古城 公佑; 南雲 義之; 池田 篤史; 松岡 ...
泌尿紀要, 2020-09 - more...
- IMvigor011: A global, double-blind, randomised phase III study of atezolizumab (atezo; anti-PD-L1) vs placebo (pbo) as adjuvant therapy in patients (pts) with high-risk muscle-invasive bladder cancer (MIBC) who are circulating tumour (ct)DNA plus post cystectomy